Lymphotoxin-beta receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappa B

被引:156
作者
VanArsdale, TL
VanArsdale, SL
Force, WR
Walter, BN
Mosialos, G
Kieff, E
Reed, JC
Ware, CF
机构
[1] UNIV CALIF RIVERSIDE,DIV BIOMED SCI,RIVERSIDE,CA 92521
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOL GENET,BOSTON,MA 02115
[4] BURNHAM INST,LA JOLLA,CA 92037
关键词
apoptosis; cytokines; signal transduction; tumor necrosis factor;
D O I
10.1073/pnas.94.6.2460
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The binding of heterotrimeric lymphotoxin, LT alpha(1) beta(2), to the LT beta receptor (LT beta R), a member of the turner necrosis factor receptor (TNFR) superfamily, induces nuclear factor kappa B (NF-kappa B) activation and cell death in HT29 adenocarcinoma cells. We now show that treatment with LT alpha(1) beta(2) or agonistic LT beta R antibodies causes rapid recruitment of TNFR-associated factor 3 (TRAF3) to the LT beta R cytoplasmic domain. Further, stable overexpression of a TRAF3 mutant that lacks the RING and zinc finger domains inhibits LT beta R-mediated cell death. The inhibition is specific for LT beta R cell death signaling, since NF-kappa B activation by LT alpha(1) beta(2) and Fas-mediated apoptosis are not inhibited in the same cells. The mutant and endogenous TRAF3s are both recruited at equimolar amounts to the LT beta R, suggesting that the mutant disrupts the function of the signaling complex. These results implicate TRAF3 as a critical component of the LT beta R death signaling complex and indicate that at least two independent signaling pathways are initiated by LT beta R ligation.
引用
收藏
页码:2460 / 2465
页数:6
相关论文
共 62 条
  • [1] ANDROLEWICZ MJ, 1992, J BIOL CHEM, V267, P2542
  • [2] RETRACTED: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation (Retracted article. See vol 94, pg 12732, 1997)
    Ansieau, S
    Scheffrahn, I
    Mosialos, G
    Brand, H
    Duyster, J
    Kaye, K
    Harada, J
    Dougall, B
    Hubinger, G
    Kieff, E
    Herrmann, F
    Leutz, A
    Gruss, HJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) : 14053 - 14058
  • [3] BANKS TA, 1995, J IMMUNOL, V155, P1685
  • [4] An essential role for NF-kappa B in preventing TNF-alpha-induced cell death
    Beg, AA
    Baltimore, D
    [J]. SCIENCE, 1996, 274 (5288) : 782 - 784
  • [5] A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN
    BOLDIN, MP
    VARFOLOMEEV, EE
    PANCER, Z
    METT, IL
    CAMONIS, JH
    WALLACH, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) : 7795 - 7798
  • [6] SELF-ASSOCIATION OF THE DEATH DOMAINS OF THE P55 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR AND FAS/APO1 PROMPTS SIGNALING FOR TNF AND FAS/APO1 EFFECTS
    BOLDIN, MP
    METT, IL
    VARFOLOMEEV, EE
    CHUMAKOV, I
    SHEMERAVNI, Y
    CAMONIS, JH
    WALLACH, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) : 387 - 391
  • [7] Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
    Boldin, MP
    Goncharov, TM
    Goltsev, YV
    Wallach, D
    [J]. CELL, 1996, 85 (06) : 803 - 815
  • [8] BROWNING J, 1989, J IMMUNOL, V143, P1859
  • [9] Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins alpha and beta
    Browning, JL
    Miatkowski, K
    Griffiths, DA
    Bourdon, PR
    Hession, C
    Ambrose, CM
    Meier, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) : 8618 - 8626
  • [10] Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines
    Browning, JL
    Miatkowski, K
    Sizing, I
    Griffiths, D
    Zafari, M
    Benjamin, CD
    Meier, W
    Mackay, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 867 - 878